Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Dec;123(12):2626-2628.e2.
doi: 10.1016/j.ophtha.2016.07.013. Epub 2016 Sep 1.

Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor

Jessica G Shantha  1 , Ian Crozier  2 , Jay B Varkey  3 , Colleen S Kraft  4 , G Marshall Lyon 3rd  3 , Aneesh K Mehta  3 , Renee Donahue Carlson  3 , Charles E Hill  5 , Gokul Kumar  1 , Matthew R Debiec  1 , Purnima S Patel  1 , Timothy W Olsen  1 , Robert B Nussenblatt  6 , Daniel F Martin  7 , Ute Ströher  8 , Timothy M Uyeki  8 , Bruce S Ribner  3 , Justine R Smith  9 , Steven Yeh  10
Affiliations
Case Reports

Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor

Jessica G Shantha et al. Ophthalmology. 2016 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Anterior segment photographs and digital imaging
(A) Slit lamp photograph of right eye with corresponding anterior segment OCT at baseline shows iris thickness of 377 μm. (B) Slit lamp photograph and anterior segment OCT at day 11 show a green iris color with iris thickening at 502 μm. (C) By day 32, slit lamp photograph shows reversal of iris color to original blue color and corresponding decrease in iris edema to 452 μm. (D) Ultrasound biomicroscopy (UBM) show normal ciliary body anatomy of the right eye. (E) UBM of left eye shows ciliary body swelling (green triangles) and supraciliary/choroidal effusion (yellow areas) consistent with progressive panuveitis, choroiditis and evolving hypotony at day 12. (F) Repeat UBM shows decreased ciliary body swelling and resolution of supraciliary/choroidal effusion (yellow arrows) by day 32. (G) B-scan ultrasound shows choroidal thickening at day 11 and repeat at day 32. (H) shows resolution of choroidal thickening.
See this image and copyright information in PMC

References

    1. Ebola situation report - 10 June 2016. World Health Organization; Geneva: 2016. http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_....
    1. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. The New England journal of medicine. 2015;372(25):2423–2427. - PMC - PubMed
    1. Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. The Lancet. Infectious diseases. 2015 - PMC - PubMed
    1. Kraft CS, Hewlett AL, Koepsell S, et al. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;61(4):496–502. - PMC - PubMed
    1. Oestereich L, Ludtke A, Wurr S, Rieger T, Munoz-Fontela C, Gunther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral research. 2014;105:17–21. - PubMed

Publication types

MeSH terms

Supplementary concepts